BioMS Medical stock up 49 per cent on licensing deal with Eli Lilly

EDMONTON - Shares in BioMS Medical Corp. (TSX:MS) rose nearly 38 per cent Tuesday, a day after the company announced a licensing and development deal with Eli Lilly and Co. on its lead multiple sclerosis compound....More